News

Before the Journals: PFO Closure in Cryptogenic Stroke


 

The full results of the CLOSURE I trial to reduce the risk of stroke in patients with patent foramen ovale who had a previous cryptogenic stroke are now published in the March 15 issue of the New England Journal of Medicine (N. Engl. J. Med. 2012;366:991-9). The results are not substantially different from our report on the results of the trial when they were presented at the American Heart Association scientific sessions in 2010 (See related story on the sidebar).

The percentages of patients who experienced the primary end points of transient ischemic attack, stroke, or the composite of the two were slightly different in the two reports, but this did not alter the results of the statistical analyses or the conclusions drawn by the investigators.

Recommended Reading

Limit Aspirin for Cancer Prevention to Patients Aged 55-75
MDedge Family Medicine
Surrogates' Emotions Influence Decisions Made for Critically Ill
MDedge Family Medicine
New Anticoagulants Promising but Problematic
MDedge Family Medicine
Desensitization Succeeds for Aspirin-Allergic Heart Patients
MDedge Family Medicine
Atrial Fibrillation, Stroke Risks Rise in Rheumatoid Arthritis
MDedge Family Medicine
Duodenal Switch May Excel at Type 2 Diabetes Resolution
MDedge Family Medicine
Slight Hyperglycemia Risk Shouldn't Deter Statin Use
MDedge Family Medicine
Role of Patent Foramen Ovale Varies in Cryptogenic Strokes
MDedge Family Medicine
Asymptomatic Carotid Disease Impairs Cognitive Function
MDedge Family Medicine
Study Hints at Statins' Protective Effect Against Parkinson's
MDedge Family Medicine

Related Articles